<DOC>
	<DOCNO>NCT00447369</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety pregabalin comparison sodium valproate migraine prevention randomize blind crossover study .</brief_summary>
	<brief_title>Efficacy Pregabalin Migraine Prevention</brief_title>
	<detailed_description>The anticonvulsant effective treatment migraine prevention . The sodium valproate demonstrate effective monotherapy migraine prevention placebo-controlled trial . Besides , new drug like gabapentin use prevention migraine good level evidence . The pregabalin anticonvulsant prove use migraine prevention similar action mechanism gabapentin . The purpose study comparison effect pregabalin sodium valproate migraine prevention randomize blind crossover study .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Migraine without aura accord International Headache Society ( IHS ) criteria least 6 month study entry . Frequency 3 headache attack per month le 15 headache attack per month . Available followup least 9 month . Exclusion criterion : Patients headache others migraine . Patients fail respond 2 adequate previous regimen migrainepreventive medication . Prophylactic drug migraine 12 week randomization . Onset migraine occur 50 year . Hypersensitivity pregabalin sodium valproate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>pregabalin</keyword>
	<keyword>Valproic acid</keyword>
	<keyword>migraine</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>prevention</keyword>
	<keyword>treatment</keyword>
</DOC>